|Rat Target Sites||Mouse Target Sites||TD50 (mg/kg/day)|
|ezy lgi liv nrv smi||cli ezy lgi liv smi||liv vsc||liv vsc||42.3m||16m|
Key to the Table Above
The Carcinogenic Potency Database (CPDB) is a unique and widely used international resource of the results of 6540 chronic, long-term animal cancer tests on 1547 chemicals. The CPDB provides easy access to the bioassay literature, with qualitative and quantitative analyses of both positive and negative experiments that have been published over the past 50 years in the general literature through 2001 and by the National Cancer Institute/National Toxicology Program through 2004. The CPDB standardizes the diverse literature of cancer bioassays that vary widely in protocol, histopathological examination and nomenclature, and in the published author’s choices of what information to provide in their papers. Results are reported in the CPDB for tests in rats, mice, hamsters, dogs, and nonhuman primates.
For each experiment, information is included on species, strain, and sex of test animal; features of experimental protocol such as route of administration, duration of dosing, dose level(s) in mg/kg body weight/day, and duration of experiment; experimental results are provided on target organ, tumor type, and tumor incidence; carcinogenic potency (TD50) and its statistical significance; shape of the dose-response, author’s opinion as to carcinogenicity, and literature citation.
Only tests with dosing for at least ¼ the standard lifespan of the species and experiment length at least ½ the lifespan are included in the CPDB. Only routes of administration with whole body exposure are included. Doses are standardized, average dose rates in mg/kg/day. A description of methods used in the CPDB to standardize the diverse literature of animal cancer tests is presented for: 1) Criteria for inclusion of experiments 2) Standardization of average daily dose levels and 3) TD50 estimation for a standard lifespan. See Methods for other details.
TD50 provides a standardized quantitative measure that can be used for comparisons and analyses of many issues in carcinogenesis. The range of TD50 values across chemicals that are rodent carcinogens is more than 100 million-fold. More than half the chemicals tested are positive in at least one experiment.
A plot of all results on each experiment in the CPDB for this chemical is presented below. These results are the source information for the Cancer Test Summary table above.
Chemical (Synonym) CAS # Species Sex Strain Route Xpo+Xpt PaperNum 0 Dose 1 Dose 2 Dose 3 Dose Literature Reference or NCI/NTP:Site Path Site Path Notes TD50 DR Pval AuOp LoConf UpConf Cntrl 1 Inc 2 Inc 3 Inc Brkly Code
Glu-P-2 (2-aminodipyrido[1,2-a:3',2'-d]imidazole) 67730-10-3 2992 M f cdf eat 82w82 1616 0 65.0mg Ohgaki;carc,5,815-819;1984 liv mix 12.0mg P<.0005 + 7.10mg 20.7mg 0/40 36/40 liv hpc 20.0mg P<.0005 12.3mg 34.4mg 0/40 30/40 blv mix 39.9mg P<.0005 + 23.3mg 76.3mg 0/40 20/40 blv hms 43.0mg P<.0005 24.8mg 83.5mg 0/40 19/40 liv hpa 170.mg P<.004 69.4mg 1.03gm 0/40 6/40 lun ade 1.09gm P<.3 178.mg n.s.s. 0/40 1/40 lun mix no dre P=1. 224.mg n.s.s. 2/40 1/40 2993 M m cdf eat 84w84 1616 0 60.0mg blv mix 23.9mg P<.0005 + 14.6mg 41.9mg 0/40 27/40 blv hms 27.3mg P<.0005 16.6mg 48.9mg 0/40 25/40 liv mix 93.2mg P<.0005 + 45.3mg 248.mg 0/40 10/40 liv hpa 201.mg P<.008 76.2mg 3.49gm 0/40 5/40 liv hpc 255.mg P<.02 87.9mg n.s.s. 0/40 4/40 lun ade 483.mg P<.5 92.2mg n.s.s. 3/40 5/40 lun mix no dre P=1. 105.mg n.s.s. 11/40 8/40 2994 R f f3d eat 24m24 1619 0 25.0mg Takayama;gann,75,207-213;1984 cli tum 56.4mg P<.0005 + 28.2mg 138.mg 0/50 11/42 col mix 81.1mg P<.0005 + 36.6mg 252.mg 0/50 8/42 smi mix 81.1mg P<.0005 + 36.6mg 252.mg 0/50 8/42 zym sqc 94.0mg P<.002 + 40.5mg 341.mg 0/50 7/42 col ade 111.mg P<.003 + 45.3mg 525.mg 0/50 6/42 smi adc 135.mg P<.005 + 51.3mg 1.12gm 0/50 5/42 smi ade 171.mg P<.02 + 59.1mg n.s.s. 0/50 4/42 col adc 351.mg P<.08 + 86.3mg n.s.s. 0/50 2/42 liv mix 351.mg P<.08 + 86.3mg n.s.s. 0/50 2/42 smi mcc 711.mg P<.3 + 116.mg n.s.s. 0/50 1/42 2995 R m f3d eat 24m24 1619 0 20.0mg smi mix 33.8mg P<.0005 + 18.1mg 73.9mg 0/50 14/42 smi adc 45.1mg P<.0005 + 22.6mg 111.mg 0/50 11/42 liv mix 52.1mg P<.003 + 24.0mg 290.mg 2/50 11/42 col mix 88.9mg P<.003 + 36.2mg 420.mg 0/50 6/42 smi ade 137.mg P<.02 + 47.3mg n.s.s. 0/50 4/42 col adc 185.mg P<.03 + 56.0mg n.s.s. 0/50 3/42 col ade 185.mg P<.03 + 56.0mg n.s.s. 0/50 3/42 smi mcc 281.mg P<.08 + 69.1mg n.s.s. 0/50 2/42 bra ast 281.mg P<.08 + 69.1mg n.s.s. 0/50 2/42 zym sqc 569.mg P<.3 + 92.6mg n.s.s. 0/50 1/42
See full CPDB Summary Table on 1547 chemicals. See Full CPDB for all results on 6540 experiments of 1547 chemicals.
A complete list of CPDB chemicals, which is searchable by name or by CAS number, is available here.
For a compendium of CPDB results organized by target organ, which lists all chemicals in each species that induced tumors in each of 35 organs, see Summary Table by Target Organ.
The CPDB is available in several formats that permit printing and downloading into spreadsheets and statistical databases.
A Supplementary Dataset gives details on dosing and survival for each experiment.
Relatively precise estimates of the lower confidence limit on the TD10 (LTD10) are readily calculated from the TD50 and its lower confidence limit, which are reported in the CPDB. For researchers and regulatory agencies interested in LTD10 values, we provide them in an Excel spreadsheet.
PDF versions of our publications of analyses using the CPDB are available, organized by year and by research topic.